Device Trial Radar · NCT06938399
Motiva Implants® Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Jul 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,400
Planned (sponsor's estimate)
Start
May 1, 2025
Primary completion
Apr 1, 2037
Study completion Jul 31, 2037
Sponsor
- Lead sponsor
- Motiva USA LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 22, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study examines the general post-market use and safety of Motiva Implants® and gathers and assesses selected safety and effectiveness data about their post market performance and experience.
Conditions
- Breast Implant
Interventions
Silicone gel-filled breast implants - Motiva Implants®Device
Breast Surgery
Aesthetic SurgeryOther
Aesthetic procedure other than breast implant surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Investigate the incidence of connective tissue disease (CTD) signs and symptoms in Motiva implanted participants compared to the incidence in control participantsTime frame: 10 Years
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
The Practice Healthcare
Beverly Hills, California · Recruiting
J. Gerald Minniti, M.D., F.A.C.S.
Beverly Hills, California · Recruiting
AESTHETX Center
Camp Pendleton, California · Recruiting
30 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.